Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016

Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17

Published:2024-01 Issue: Volume:254 Page:111040
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Heimer Robert^ORCID,Black Anne C.,Lin Hsiuju^ORCID,Grau Lauretta E.,Fiellin David A.,Howell Benjamin A.,Hawk Kathryn^ORCID,D’Onofrio Gail,Becker William C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference38 articles.

1. Connecticut Dept of Mental Health and Addiction Services Provider Quality Dashboard;Anonymous,2022

2. Aschengrau, A., Seage, G.R., 2008. Essentials of Epidemiology in Public Health (Jones and Bartlett: Sudbury, MA).

3. Merging statewide data in a public/university collaboration to address opioid use disorder and overdose;Becker;Addict. Sci. Clin. Pract.,2021

4. Deaths of Despair: a scoping review on the social determinants of drug overdose, alcohol-related liver disease and suicide;Beseran;Int. J. Environ. Res. Public Health,2022

5. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months;Broers;Drug Alcohol Depend.,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina;Journal of Substance Use and Addiction Treatment;2024-12

2. Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment;JAMA Internal Medicine;2024-08-26

3. Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal;JAMA Network Open;2024-07-08

4. Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada;BMJ Open;2024-02